Author: admin

The stakeholder Meeting “Shaping regulatory science to 2025” took place at the EMA in London on Wednesday, 24 October 2018. EUCROF attended, represented by Dr Martine Dehlinger-Kremer. The aim of the meeting was to gather insight from stakeholders on the...

On Thursday and Friday next week, the “Better Medicines for Children” Meeting (DIA/EFGCP) will take place in Brussels. EUCROF will be represented by its President, Martine Dehlinger-Kremer, its Vice-President, Dr Stefano Marini, together with Dr Dagmar Chase. Martine Dehlinger-Kremer will...

The Clinical Trial Facilitation Group (CTFG) Stakeholder Meeting will take place in Bonn on Wednesday, 24 October 2018. The meeting will develop the following topics: EUCROF will be attending, represented by Dr Stefano Marini and Dr Dagmar Chase. Kindly click...

Applied Clinical Trials published in its Volume 26, Issue 10, a paper called “The Shifting Perspectives on Pharmacovigilance in Europe” including some highlights and a link to the paper prepared by the EUCROF PharmacoVigilance Working Group on the EUCROF website....

According to recent GVP module VI Revision 2, from 22 NOV 2017 non-serious ADRs from the market in Europe should be submitted to EMA/Eudravigilance within 90 days. This new updated GVP module also applies to non-interventional studies. This may have...

On 25 April 2017, EUCROF, represented by Dr Martine Dehlinger-Kremer, has been invited to speak about the new EU Clinical Trials Regulation at “Clinical  Trials in Central &Easter Europe Forum” in Budapest.

On 25 April 2017, EUCROF, represented by Dr Martine Dehlinger-Kremer, has been invited to speak about the new EU Clinical Trials Regulation at “Clinical  Trials in Central &Easter Europe Forum” in Budapest.

EUCROF, represented by Dr Martine Dehlinger-Kremer, will be speaking at the “International Pediatric Clinical Trial Day 2017 – Helping children create lives they deserve” on 09 May 2017 in Milan.